The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
miR‐155 modulates microglia‐mediated immune response by down‐regulating SOCS‐1 and promoting cytokine and nitric oxide production
Open accessAbstract
Innate immunity constitutes the first line of defence against both external and endogenous threats in the brain, and microglia cells are considered key mediators of this process. Recent studies have shown that microRNAs (miRNAs) may play a determinant role in the regulation of gene expression during innate immune responses. The major goal of this work was to investigate the contribution of a specific miRNA - miR-155 - to the modulation of the microglia-mediated immune response. For this purpose, in vitro studies were performed in N9 microglia cells to evaluate changes in the levels of this miRNA following microglia activation. A strong up-regulation of miR-155 expression was observed following microglia exposure to lipopolysaccharide, which was consistent with a decrease in the levels of the suppressor of cytokine signalling 1 (SOCS-1) protein, a key inhibitor of the inflammatory process and a predicted target of miR-155. The miR-155 knockdown by anti-miRNA oligonucleotides up-regulated SOCS-1 mRNA and protein levels and significantly decreased the production of nitric oxide and the expression of inflammatory cytokines and inducible nitric oxide synthase. Finally, treatment of neuronal primary cultures with conditioned medium obtained from microglia cells, in which miR-155 was inhibited before cell activation, decreased inflammatory-mediated neuronal cell death. Overall, our results show that miR-155 has a pro-inflammatory role in microglia and is necessary for the progression of the immune response through the modulation of SOCS-1, suggesting that, in a chronic inflammatory context, miR-155 inhibition can have a neuroprotective effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardoso et al., based on findings in other myeloid-derived cells, demonstrated that miR-155 is induced by LPS in a mouse N9 microglia cell line and in primary cultures. Similar to other authors [244], they confirmed targeting of the suppressor of the cytokine signaling 1 gene (SOCS1) by miR-155.”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [237]
In the citing paper
“For example, neuron-derived EVs enriched in miR-132-3p or miR-124-3p can reprogram glial states, while glial EV cargo such as miR-155, miR-21-5p, and miR-146a feeds back onto neurons and other glia to propagate inflammatory or compensatory signals (Aloi et al., 2023; Cardoso et al., 2011; Fan et al., 2020; Gaudet et al., 2017; Guedes et al., 2014; Han et al., 2020; Lukiw et al., 2008; Saba et al.,”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“MiR-155 is one of the strongest determinants of microglial pathogenicity. Its upregulation in AD microglia enhances NF-κB signaling, increases production of pro-inflammatory cytokines, and reduces phagocytic Aβ clearance, thereby worsening plaque burden and neuronal injury (Cardoso et al., 2011; Guedes et al., 2014).”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“MiR-155 is also induced in reactive astrocytes and is associated with pro-inflammatory glial reprogramming.”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“Astrocytic and microglial miRNAs, including miR-21-5p, miR-155, miR-33, miR-146a, and miR-181c-5p, govern processes such as NF-κB–dependent inflammatory activation, ApoE/ABCA1 lipid pathways, and microglial plaque-associated phenotypes (Aloi et al., 2023; Cardoso et al., 2011; Fan et al., 2020; Garcia et al., 2022; Hansen et al., 2017; Hutchison et al., 2013; Li et al., 2024; Lukiw et al., 2008; O”
From Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer’s disease (2026) · cites this paper as Cardoso et al., 2011
In the citing paper
“Thus, miR-155 and miR-146a were shown to increase in the microglial cells in response to stimulation with Lipopolysaccharides (LPS) and Polyinosinic-polycytidylic acid (poly(I:C), respectively, and they seem to play a fundamental role in the microglial inflammatory profile [13,14].”
From miR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses (2014) · cites this paper as [13]
In the citing paper
“Recently, a study showed that miR-155 leads to the increase of inflammatory factors such as inducible nitrogen synthase (iNOS), IL-6 and TNF-α, and thus the neurotoxic response for activated microglia to switch to the M1 phenotype (Cardoso et al. 2012).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Cardoso et al. 2012
In the citing paper
“A study showed that non-viral vector can help silencing miR-155 in microglia before activation, decrease NO release and inflammatory factors, and include TNF-α and IL-6 in the microenvironment via upregulation of SOCS-1, a direct target of miR-155. This method can improve neuronal viability and inhibit microglial activation through miRNA modulation in microglial cells (Cardoso et al. 2012).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Cardoso et al. 2012
Citations
Cites
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304
Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis
Stańczyk, J., Pedrioli, D. M. L., Brentano, F., Sánchez‐Pernaute, O., Kolling, C., Gay, R. E., Detmar, M. J., Gay, S., & Kyburz, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23386 · Cited by 911
miR-155 gene: A typical multifunctional microRNA
Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 815
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754
Jiang, S., Zhang, H.-W., Lu, M.-H., He, X.-H., Li, Y., Gu, H., Liu, M.-F., & Wang, E.-D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4250 · Cited by 679
Research works printed but not linked: 1
- 10.1097/01.WCB.0000061881.75234.5E · DOI · Paper page
Cited by
Sorted by citations
The biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655
Alternatively activated microglia and macrophages in the central nervous system
Franco, R., & Fernández‐Suárez, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.003 · Cited by 674
Roles of microglia in brain development, tissue maintenance and repair
Michell‐Robinson, M. A., Touil, H., Healy, L. M., Owen, D. R., Durafourt, B. A., Bar‐Or, A., Antel, J. P., & Moore, C. S. (2015) · Brain · doi:10.1093/brain/awv066 · Cited by 435
Microglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
Kempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S. A., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P., Iyer, S. S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00216 · Cited by 382
Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
de Vries, E. E., van den Munckhof, B., Braun, K. P. J., van Royen‐Kerkhof, A., de Jager, W., & Jansen, F. E. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.007 · Cited by 271
MicroRNAs: Roles in Regulating Neuroinflammation
Gaudet, A. D., Fonken, L. K., Watkins, L. R., Nelson, R. J., & Popovich, P. G. (2018) · The Neuroscientist · doi:10.1177/1073858417721150 · Cited by 236
Slota, J. A., & Booth, S. A. (2019) · Non-Coding RNA · doi:10.3390/ncrna5020035 · Cited by 240
Brain-immune interactions in perinatal hypoxic-ischemic brain injury
Li, B., Concepcion, K. R., Meng, X., & Zhang, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.006 · Cited by 236
Glial Cells Shape Pathology and Repair After Spinal Cord Injury
Gaudet, A. D., & Fonken, L. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0630-7 · Cited by 242
miR‐155 as a multiple sclerosis–relevant regulator of myeloid cell polarization
Moore, C. S., Rao, V. T. S., Durafourt, B. A., Bedell, B. J., Ludwin, S. K., Bar‐Or, A., & Antel, J. P. (2013) · Annals of Neurology · doi:10.1002/ana.23967 · Cited by 219
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 213
Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia
Amici, S. A., Dong, J., & Guerau‐de‐Arellano, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01520 · Cited by 200
Manu, D. R., SLEVIN, M. A., Bărcuţean, L., Forró, T., Boghițoiu, T., & Bălașa, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417146 · Cited by 209
Matias, D., Balça-Silva, J., da Graça, G. C., Muriithi, W., Macharia, L. W., Nascimento, C. P., Roque, N. R., Coelho‐Aguiar, J. M., Pereira, C. M., DosSantos, M. F. H., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00235 · Cited by 194
Role of mi R ‐155 in the regulation of lymphocyte immune function and disease
Seddiki, N., Brezar, V., Ruffin, N., Lévy, Y., & Swaminathan, S. (2013) · Immunology · doi:10.1111/imm.12227 · Cited by 176
miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
Varendi, K., Kumar, A., Härma, M.-A., & Andressoo, J.-O. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1628-x · Cited by 170
MicroRNAs as regulators of brain function and targets for treatment of epilepsy
Brennan, G. P., & Henshall, D. C. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0369-8 · Cited by 169
Guedes, J. R., Custódia, C. M., Silva, R. J., de Almeida, L. P., Pedroso de Lima, M. C., & Cardoso, A. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu348 · Cited by 170
Self-citationMiR-155: An Important Regulator of Neuroinflammation
Zingale, V. D., Gugliandolo, A., & Mazzon, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010090 · Cited by 163
Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia
Freilich, R. W., Woodbury, M. E., & Ikezu, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079416 · Cited by 160
A Virus‐Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy
Gao, X., Li, S., Ding, F., Liu, X., Wu, Y., Li, J., Feng, J. C., Zhu, X., & Zhang, C. (2021) · Advanced Materials · doi:10.1002/adma.202006116 · Cited by 160
Microglia change from a reactive to an age-like phenotype with the time in culture
Caldeira, C., Oliveira, A. F., Cunha, C., Vaz, A. R., Falcão, A. S., Fernandes, A., & Brites, D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00152 · Cited by 156
MiR-9 promotes microglial activation by targeting MCPIP1
Yao, H., Ma, R., Yang, L., Hu, G., Chen, X., Duan, M., Kook, Y., Niu, F., Liao, K., Fu, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5386 · Cited by 158
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents
Khoshnam, S. E., Winlow, W., Farbood, Y., Moghaddam, H. F., & Farzaneh, M. (2017) · Journal of Stroke · doi:10.5853/jos.2016.01368 · Cited by 156
Kaminska, B., Mota, M., & Pizzi, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.026 · Cited by 161
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
Cunha, C., Gomes, C., Vaz, A. R., & Brites, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6986175 · Cited by 153
Epigenetics Control Microglia Plasticity
Cheray, M., & Joseph, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00243 · Cited by 157
Guo, Y.-W., Hong, W., Wang, X., Zhang, P., Körner, H., Tu, J., & Wei, W. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00125 · Cited by 153
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 151
Lippai, D., Bala, S., Csak, T., Kurt-Jones, E. A., & Szabo, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070945 · Cited by 129
Thounaojam, M. C., Kundu, K., Kaushik, D. K., Swaroop, S., Mahadevan, A., Shankar, S. K., & Basu, A. (2014) · Journal of Virology · doi:10.1128/jvi.02979-13 · Cited by 119
MicroRNAs mediating CNS inflammation: Small regulators with powerful potential
Su, W., Aloi, M. S., & Garden, G. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.003 · Cited by 139
Quero, L., Tiaden, A. N., Hanser, E., Roux, J., Łaski, A., Hall, J., & Kyburz, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03087 · Cited by 140
Pinto, S., Cunha, C., Barbosa, M., Vaz, A. R., & Brites, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00273 · Cited by 135
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Walgrave, H., Zhou, L., Strooper, B. D., & Salta, E. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00496-7 · Cited by 137
Regulation of MicroRNA-155 in Atherosclerotic Inflammatory Responses by Targeting MAP3K10
Zhu, J., Chen, T., Yang, L., Li, Z., Wong, M. M., Zheng, X., Pan, X., Zhang, L., & Yan, H. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046551 · Cited by 126
Karkeni, E., Astier, J., Tourniaire, F., Abed, M. E., Romier, B., Gouranton, E., Wan, L., Borel, P., Salles, J., Walrand, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3410 · Cited by 127
Pathak, S., Grillo, A. R., Scarpa, M., Brun, P., Renata D'Incà, Nai, L., Banerjee, A., Cavallo, D., Barzon, L., Palù, G., et al. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.21 · Cited by 125
Pareek, S., Roy, S., Kumari, B., Jain, P., Banerjee, A., & Vrati, S. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-97 · Cited by 121
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Caggiu, E., Paulus, K. S., Mameli, G., Arru, G., Sechi, G., & Sechi, L. A. (2018) · eNeurologicalSci · doi:10.1016/j.ensci.2018.09.002 · Cited by 119
MicroRNAs and HIV-1 Infection: Antiviral Activities and Beyond
Swaminathan, G., Navas, S., & Martín‐García, J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.017 · Cited by 116
Emerging Roles of miRNAs in Brain Development and Perinatal Brain Injury
Cho, K. H. T., Xu, B., Blenkiron, C., & Fraser, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00227 · Cited by 115
Protective Microglia and Their Regulation in Parkinson’s Disease
Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 123
In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response
Pena-Philippides, J. C., Caballero-Garrido, E., Lordkipanidze, T., & Roitbak, T. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0753-x · Cited by 112
Microglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103
Berríos‐Cárcamo, P., Quezada, M., Quintanilla, M. E., Morales, P., Ezquer, M., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2020) · Antioxidants · doi:10.3390/antiox9090830 · Cited by 115
MicroRNA based theranostics for brain cancer: basic principles
Petrescu, G. E. D., Sabo, A. A., Torsin, L. I., Călin, G. A., & Dragomir, M. P. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1180-5 · Cited by 110
Thounaojam, M. C., Kaushik, D. K., Kundu, K., & Basu, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12609 · Cited by 101
Su, W., Hopkins, S., Nesser, N. K., Sopher, B., Silvestroni, A., Ammanuel, S., Jayadev, S., Möller, T., Weinstein, J., & Garden, G. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301397 · Cited by 103
Cannella, D., Brenier‐Pinchart, M., Braun, L., van Rooyen, J. M., Bougdour, A., Bastien, O., Behnke, M. S., Curt, R.-L., Curt, A., Saeij, J. P. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.002 · Cited by 102
MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review
Nies, Y. H., Najib, N. H. M., Lim, W. L., Kamaruzzaman, M. A., Yahaya, M. F., & Teoh, S. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.660379 · Cited by 105
Lippai, D., Bala, S., Catalano, D. E., Kodys, K., & Szabó, G. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12483 · Cited by 100
Converging Actions of Alcohol on Liver and Brain Immune Signaling
Szabó, G., & Lippai, D. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00011-7 · Cited by 96
miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction
Woodbury, M. E., Freilich, R. W., Cheng, C. J., Asai, H., Ikezu, S., Boucher, J. D., Slack, F. J., & Ikezu, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4790-14.2015 · Cited by 96
Suppression of MicroRNA-155 Attenuates Neuropathic Pain by Regulating SOCS1 Signalling Pathway
Tan, Y., Yang, J. H., Xiang, K., Tan, Q., & Guo, Q. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1500-2 · Cited by 94
Fernandes, A., Ribeiro, A. R., Monteiro, M., Garcia, G., Vaz, A. R., & Brites, D. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.015 · Cited by 93
Ye, Y., He, X., Lu, F., Mao, H., Zhu, Z., Yao, L., Luo, W., Sun, X., Wang, B., Qian, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0821-5 · Cited by 95
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
Rasheed, M., Liang, J., Wang, C., Deng, Y., & Chen, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094956 · Cited by 96
miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling
Collins, A. S., McCoy, C. E., Lloyd, A. T., O’Farrelly, C., & Stevenson, N. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069090 · Cited by 89
miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
Maciak, K., Dziedzic, A., Miller, E. D., & Saluk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094332 · Cited by 90
Gaudet, A. D., Mandrekar-Colucci, S., Hall, J. C. E., Sweet, D. R., Schmitt, P., Xu, X., Guan, Z., Mo, X. M., Guerau‐de‐Arellano, M., & Popovich, P. G. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0735-16.2016 · Cited by 91
Cunha, C., Santos, C., Gomes, C., Fernandes, A. M. A., Correia, A. M., Sebastião, A. M., Vaz, A. R., & Brites, D. M. T. O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0631-2 · Cited by 88
Epigenetic reprogramming of immune cells in injury, repair, and resolution
Placek, K., Schultze, J. L., & Aschenbrenner, A. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124619 · Cited by 86
The old guard: Age-related changes in microglia and their consequences
Costa, J., Martins, S., Ferreira, P. A., Cardoso, A. M., Guedes, J. R., Peça, J., & Cardoso, A. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111512 · Cited by 88
Self-citationNeuroinflammation in Ischemic Stroke: Focus on MicroRNA-mediated Polarization of Microglia
Lian, L., Zhang, Y., Liu, L., Yang, L., Cai, Y., Zhang, J., & Xu, S. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.612439 · Cited by 83
Rao, R., Nagarkatti, P. S., & Nagarkatti, M. (2014) · Infection and Immunity · doi:10.1128/iai.01666-14 · Cited by 83
Qiu, S., Feng, Y., LeSage, G., Zhang, Y., Stuart, C. A., He, L., Li, Y., Caudle, Y., Peng, Y., & Yin, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400106 · Cited by 82
Henry, R. J., Doran, S. J., Barrett, J. P., Meadows, V. E., Sabirzhanov, B. E., Stoica, B. A., Loane, D. J., & Faden, A. I. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0665-9 · Cited by 84
Eren, E., Tüfekçi, K. U., Isci, K. B., Tastan, B., Genç, K., & Genç, Ş. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00036 · Cited by 84
The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets
Xu, W., Gao, L., Zheng, J., Li, T., Shao, A., Reis, C., Chen, S., & Zhang, J. (2018) · Cell Transplantation · doi:10.1177/0963689718773361 · Cited by 85
Costa, P. M., Cardoso, A. L., Nóbrega, C., Pereira de Almeida, L. F., Bruce, J. N., Canoll, P., & Pedroso de Lima, M. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds496 · Cited by 80
Self-citationEpigenetics: The third pillar of nitric oxide signaling
Socco, S., Bovee, R. C., Palczewski, M. B., Hickok, J. R., & Thomas, D. D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.011 · Cited by 80
Gomes, C., Cunha, C., Nascimento, F., Ribeiro, J. A., Vaz, A. R., & Brites, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1220-8 · Cited by 79
Involvement of MicroRNA in Microglia-Mediated Immune Response
Guedes, J., Cardoso, A. L. C., & Pedroso de Lima, M. C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/186872 · Cited by 65
Self-citationTong, L., Shao, A., Ou, Y., Guo, Z., Manaenko, A., Dixon, B. J., Tang, J., Lou, M., & Zhang, J. H. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16658490 · Cited by 77
Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia.
Hunsberger, J. G., Fessler, E. B., Wang, Z., ELKAHLOUN, A. G., & Chuang, D. (2012) · Europe PMC (PubMed Central) · Cited by 77
MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease
Guedes, J. R., Santana, I. J., Cunha, C., Duro, D., Almeida, M. R., Cardoso, A. M., de Lima, M. C. P., & Cardoso, A. L. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.004 · Cited by 77
Self-citationMiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3
Xu, G., Yang, F., Ding, C., Wang, J., Zhao, P., Wang, W., & Ren, H. (2014) · Virology · doi:10.1016/j.virol.2014.06.024 · Cited by 75
Macrophage micro-RNA-155 promotes lipopolysaccharide-induced acute lung injury in mice and rats
Wang, W., Liu, Z., Su, J., Chen, W., Wang, X.-W., Bai, S.-X., Zhang, J., & Yu, S. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00001.2016 · Cited by 74
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation
Matt, S. M., & Johnson, R. W. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.009 · Cited by 75
Critical Role of MicroRNA-155 in Herpes Simplex Encephalitis
Bhela, S., Mulik, S., Reddy, P. B. J., Richardson, R. L., Giménez, F., Rajasagi, N. K., Veiga‐Parga, T., Osmand, A. P., & Rouse, B. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302326 · Cited by 70
Epigenetics and the Modulation of Neuroinflammation
Garden, G. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0207-4 · Cited by 70
Liu, X., Ma, J., Ding, G., Gong, Q., Wang, Y., Yu, H., & Cheng, X. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5753452 · Cited by 70
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions
Cardoso, A. L., Guedes, J. R., & de Lima, M. C. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.001 · Cited by 71
Self-citationThe Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke
Khoshnam, S. E., Winlow, W., & Farzaneh, M. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx036 · Cited by 69
Hong, P., Jiang, M. H., & Li, H. (2014) · Glia · doi:10.1002/glia.22725 · Cited by 70
Danka Mohammed, C. P., Park, J. S., Nam, H. G., & Kim, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.01.007 · Cited by 69
Gypenoside AttenuatesβAmyloid-Induced Inflammation in N9 Microglial Cells via SOCS1 Signaling
Cai, H., Liang, Q., & Ge, G. (2016) · Neural Plasticity · doi:10.1155/2016/6362707 · Cited by 68
LaRocca, D., Barns, S., Hicks, S. D., Brindle, A., Williams, J. R., Uhlig, R., Johnson, P. R., Neville, C., & Middleton, F. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0207785 · Cited by 68
Gong, T., Liu, Y.-T., & Fan, J. (2024) · Military Medical Research · doi:10.1186/s40779-024-00527-6 · Cited by 73
MicroRNA-155 induction by Mycobacterium bovis BCG enhances ROS production through targeting SHIP1
Wang, J., Wu, M., Wen, J., Yang, K., Li, M., Zhan, X., Feng, L., Li, M., & Huang, X. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.012 · Cited by 67
Guo, J., Liao, M., & Wang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00771-6 · Cited by 66
microRNA‐200b modulates microglia‐mediated neuroinflammation via the cJun/MAPK pathway
Jadhav, S. P., Kamath, S. P., Choolani, M. A., Lu, J., & Dheen, S. T. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12731 · Cited by 66
Gupta, N., Shyamasundar, S., Patnala, R., Karthikeyan, A., Arumugam, T. V., Ling, E., & Dheen, S. T. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1515917 · Cited by 67
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Gentile, G., Morello, G., Cognata, V. L., Guarnaccia, M., Conforti, F. L., & Cavallaro, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050770 · Cited by 71
Rastegar-Moghaddam, S. H., Ebrahimzadeh-Bideskan, A., Shahba, S., Malvandi, A. M., & Mohammadipour, A. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01200-z · Cited by 64
Ma, C., Wang, Y., Shen, A., & Cai, W. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2802 · Cited by 64
Caplan, I. F., & Maguire‐Zeiss, K. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00417 · Cited by 68
Hu, J., Huang, C., Rao, P., Zhou, J., Wang, X., Tang, L., Liu, M., & Zhang, G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.001 · Cited by 63
Metadata
- Authors
- Cardoso, A. L., Guedes, J. R., Pereira de Almeida, L., & Pedroso de Lima, M. C.
- Affiliations
- Centro de Neurociências e Biologia Celular (PT)
- University of Coimbra (PT)
- Corresponding author
- Cardoso, Ana L.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2011-12-07
- Volume
- 135
- Issue
- 1
- Pages
- 73-88
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- PMC
- PMC3246654
- OpenAlex
- W2095876795
- Cited by
- 336
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 17 · 2023: 26 · 2022: 21 · 2021: 29 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 26 · 2016: 25 · 2015: 20 · 2014: 29 · 2013: 15 · 2012: 5
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- miR-155, microglia, SOCS1, innate immunity, neuroinflammation, lipopolysaccharide, nitric oxide, inducible nitric oxide synthase, inflammatory cytokines, microglial activation, neuronal cell death, neuroprotection, antagomir
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Animals, Cells, Cultured, Lipopolysaccharides, Nitric Oxide, Down-Regulation, Up-Regulation, Cytokines, Microglia, MicroRNAs, Suppressor of Cytokine Signaling Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
